vs
Certara, Inc.（CERT）与GLAUKOS Corp（GKOS）财务数据对比。点击上方公司名可切换其他公司
GLAUKOS Corp的季度营收约是Certara, Inc.的1.5倍（$150.6M vs $103.6M），GLAUKOS Corp净利率更高（6.2% vs -5.7%，领先11.9%），GLAUKOS Corp同比增速更快（41.2% vs 3.3%），过去两年GLAUKOS Corp的营收复合增速更高（25.4% vs 3.6%）
Certara是全球领先的生物制药软件及咨询服务提供商，专注于建模模拟、监管科学领域的解决方案，服务药企、生物技术企业及医疗相关方，覆盖药物研发全周期，助力加快新疗法上市，降低研发风险与综合成本。
Glaukos Corp是一家专注于眼科领域的医疗科技企业，开发并商业化用于治疗青光眼、角膜疾病等眼部病症的微创手术器械、处方药物及消费级产品，主要市场覆盖北美、欧洲及亚太地区，为全球医院、眼科诊所及患者提供服务。
CERT vs GKOS — 直观对比
营收规模更大
GKOS
是对方的1.5倍
$103.6M
营收增速更快
GKOS
高出37.9%
3.3%
净利率更高
GKOS
高出11.9%
-5.7%
两年增速更快
GKOS
近两年复合增速
3.6%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $103.6M | $150.6M |
| 净利润 | $-5.9M | $9.4M |
| 毛利率 | — | 77.9% |
| 营业利润率 | 0.8% | 9.0% |
| 净利率 | -5.7% | 6.2% |
| 营收同比 | 3.3% | 41.2% |
| 净利润同比 | -189.6% | — |
| 每股收益（稀释后） | $-0.04 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CERTGKOS
| Q1 26 | — | $150.6M | ||
| Q4 25 | $103.6M | $143.1M | ||
| Q3 25 | $104.6M | $133.5M | ||
| Q2 25 | $104.6M | $124.1M | ||
| Q1 25 | $106.0M | $106.7M | ||
| Q4 24 | $100.4M | $105.5M | ||
| Q3 24 | $94.8M | $96.7M | ||
| Q2 24 | $93.3M | $95.7M |
净利润CERTGKOS
| Q1 26 | — | $9.4M | ||
| Q4 25 | $-5.9M | $-133.7M | ||
| Q3 25 | $1.5M | $-16.2M | ||
| Q2 25 | $-2.0M | $-19.7M | ||
| Q1 25 | $4.7M | $-18.1M | ||
| Q4 24 | $6.6M | $-33.6M | ||
| Q3 24 | $-1.4M | $-21.4M | ||
| Q2 24 | $-12.6M | $-50.5M |
毛利率CERTGKOS
| Q1 26 | — | 77.9% | ||
| Q4 25 | — | -1.1% | ||
| Q3 25 | — | 78.4% | ||
| Q2 25 | — | 78.3% | ||
| Q1 25 | — | 77.2% | ||
| Q4 24 | — | 72.9% | ||
| Q3 24 | — | 76.6% | ||
| Q2 24 | — | 76.4% |
营业利润率CERTGKOS
| Q1 26 | — | 9.0% | ||
| Q4 25 | 0.8% | -97.7% | ||
| Q3 25 | 2.9% | -12.3% | ||
| Q2 25 | 9.1% | -18.3% | ||
| Q1 25 | 7.2% | -19.4% | ||
| Q4 24 | 6.0% | -27.2% | ||
| Q3 24 | 2.7% | -25.5% | ||
| Q2 24 | -9.7% | -31.3% |
净利率CERTGKOS
| Q1 26 | — | 6.2% | ||
| Q4 25 | -5.7% | -93.4% | ||
| Q3 25 | 1.5% | -12.2% | ||
| Q2 25 | -1.9% | -15.8% | ||
| Q1 25 | 4.5% | -17.0% | ||
| Q4 24 | 6.6% | -31.8% | ||
| Q3 24 | -1.4% | -22.1% | ||
| Q2 24 | -13.5% | -52.8% |
每股收益（稀释后）CERTGKOS
| Q1 26 | — | — | ||
| Q4 25 | $-0.04 | $-2.34 | ||
| Q3 25 | $0.01 | $-0.28 | ||
| Q2 25 | $-0.01 | $-0.34 | ||
| Q1 25 | $0.03 | $-0.32 | ||
| Q4 24 | $0.04 | $-0.56 | ||
| Q3 24 | $-0.01 | $-0.39 | ||
| Q2 24 | $-0.08 | $-1.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $189.4M | $276.7M |
| 总债务越低越好 | $293.1M | — |
| 股东权益账面价值 | $1.1B | $670.9M |
| 总资产 | $1.6B | $893.3M |
| 负债/权益比越低杠杆越低 | 0.28× | — |
8季度趋势，按日历期对齐
现金及短期投资CERTGKOS
| Q1 26 | — | $276.7M | ||
| Q4 25 | $189.4M | $90.8M | ||
| Q3 25 | $172.7M | $98.2M | ||
| Q2 25 | $162.3M | $100.8M | ||
| Q1 25 | $179.1M | $114.3M | ||
| Q4 24 | $179.2M | $169.6M | ||
| Q3 24 | $233.0M | $100.1M | ||
| Q2 24 | $224.6M | $68.1M |
总债务CERTGKOS
| Q1 26 | — | — | ||
| Q4 25 | $293.1M | — | ||
| Q3 25 | $293.5M | — | ||
| Q2 25 | $294.2M | — | ||
| Q1 25 | $294.8M | — | ||
| Q4 24 | $295.4M | — | ||
| Q3 24 | $296.1M | — | ||
| Q2 24 | $296.7M | — |
股东权益CERTGKOS
| Q1 26 | — | $670.9M | ||
| Q4 25 | $1.1B | $656.2M | ||
| Q3 25 | $1.1B | $769.5M | ||
| Q2 25 | $1.1B | $765.1M | ||
| Q1 25 | $1.1B | $764.0M | ||
| Q4 24 | $1.1B | $766.9M | ||
| Q3 24 | $1.1B | $668.5M | ||
| Q2 24 | $1.0B | $665.2M |
总资产CERTGKOS
| Q1 26 | — | $893.3M | ||
| Q4 25 | $1.6B | $893.5M | ||
| Q3 25 | $1.5B | $999.4M | ||
| Q2 25 | $1.5B | $987.0M | ||
| Q1 25 | $1.6B | $966.2M | ||
| Q4 24 | $1.6B | $974.8M | ||
| Q3 24 | $1.5B | $926.5M | ||
| Q2 24 | $1.5B | $919.7M |
负债/权益比CERTGKOS
| Q1 26 | — | — | ||
| Q4 25 | 0.28× | — | ||
| Q3 25 | 0.28× | — | ||
| Q2 25 | 0.27× | — | ||
| Q1 25 | 0.27× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 0.28× | — | ||
| Q2 24 | 0.28× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $28.8M | — |
| 自由现金流经营现金流 - 资本支出 | $27.8M | — |
| 自由现金流率自由现金流/营收 | 26.8% | — |
| 资本支出强度资本支出/营收 | 1.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $94.4M | — |
8季度趋势，按日历期对齐
经营现金流CERTGKOS
| Q1 26 | — | — | ||
| Q4 25 | $28.8M | $6.8M | ||
| Q3 25 | $32.3M | $-10.1M | ||
| Q2 25 | $17.8M | $7.0M | ||
| Q1 25 | $17.4M | $-18.5M | ||
| Q4 24 | $49.4M | $507.0K | ||
| Q3 24 | $17.0M | $-9.6M | ||
| Q2 24 | $9.8M | $-18.4M |
自由现金流CERTGKOS
| Q1 26 | — | — | ||
| Q4 25 | $27.8M | $3.9M | ||
| Q3 25 | $32.1M | $-11.7M | ||
| Q2 25 | $17.8M | $5.8M | ||
| Q1 25 | $16.8M | $-20.5M | ||
| Q4 24 | $49.0M | $-1.2M | ||
| Q3 24 | $16.8M | $-11.0M | ||
| Q2 24 | $9.4M | $-20.5M |
自由现金流率CERTGKOS
| Q1 26 | — | — | ||
| Q4 25 | 26.8% | 2.7% | ||
| Q3 25 | 30.7% | -8.8% | ||
| Q2 25 | 17.0% | 4.7% | ||
| Q1 25 | 15.8% | -19.2% | ||
| Q4 24 | 48.8% | -1.2% | ||
| Q3 24 | 17.7% | -11.4% | ||
| Q2 24 | 10.1% | -21.4% |
资本支出强度CERTGKOS
| Q1 26 | — | — | ||
| Q4 25 | 1.0% | 2.0% | ||
| Q3 25 | 0.2% | 1.2% | ||
| Q2 25 | 0.1% | 0.9% | ||
| Q1 25 | 0.6% | 1.8% | ||
| Q4 24 | 0.4% | 1.6% | ||
| Q3 24 | 0.2% | 1.5% | ||
| Q2 24 | 0.5% | 2.2% |
现金转化率CERTGKOS
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 21.19× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.66× | — | ||
| Q4 24 | 7.51× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
